189 related articles for article (PubMed ID: 16732286)
21. Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer.
Sarraf-Yazdi S; Mi J; Moeller BJ; Niu X; White RR; Kontos CD; Sullenger BA; Dewhirst MW; Clary BM
J Surg Res; 2008 May; 146(1):16-23. PubMed ID: 17950331
[TBL] [Abstract][Full Text] [Related]
22. Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands.
Seegar TC; Eller B; Tzvetkova-Robev D; Kolev MV; Henderson SC; Nikolov DB; Barton WA
Mol Cell; 2010 Mar; 37(5):643-55. PubMed ID: 20227369
[TBL] [Abstract][Full Text] [Related]
23. Structure of the extracellular domain of Tie receptor tyrosine kinases and localization of the angiopoietin-binding epitope.
Macdonald PR; Progias P; Ciani B; Patel S; Mayer U; Steinmetz MO; Kammerer RA
J Biol Chem; 2006 Sep; 281(38):28408-14. PubMed ID: 16849318
[TBL] [Abstract][Full Text] [Related]
24. Interaction between Tie receptors modulates angiogenic activity of angiopoietin2 in endothelial progenitor cells.
Kim KL; Shin IS; Kim JM; Choi JH; Byun J; Jeon ES; Suh W; Kim DK
Cardiovasc Res; 2006 Dec; 72(3):394-402. PubMed ID: 17054925
[TBL] [Abstract][Full Text] [Related]
25. Rapamycin and cyclosporine have different effects on expression of Ang-1 and Ang-2 and Tie2 in rat renal allograft with chronic allograft nephropathy.
Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
Transplant Proc; 2008 Oct; 40(8):2804-7. PubMed ID: 18929866
[TBL] [Abstract][Full Text] [Related]
26. Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia.
Schliemann C; Bieker R; Padro T; Kessler T; Hintelmann H; Buchner T; Berdel WE; Mesters RM
Haematologica; 2006 Sep; 91(9):1203-11. PubMed ID: 16956819
[TBL] [Abstract][Full Text] [Related]
27. Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2.
Kim KT; Choi HH; Steinmetz MO; Maco B; Kammerer RA; Ahn SY; Kim HZ; Lee GM; Koh GY
J Biol Chem; 2005 May; 280(20):20126-31. PubMed ID: 15769741
[TBL] [Abstract][Full Text] [Related]
28. Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer.
Szarvas T; Jäger T; Tötsch M; vom Dorp F; Kempkensteffen C; Kovalszky I; Romics I; Ergün S; Rübben H
Clin Cancer Res; 2008 Dec; 14(24):8253-62. PubMed ID: 19088043
[TBL] [Abstract][Full Text] [Related]
29. Discovery of loperamide as an antagonist of angiopoietin1 and angiopoietin2 by virtual screening.
Gong XW; Mai JH; Xu YH
Bioorg Med Chem Lett; 2012 Apr; 22(7):2388-92. PubMed ID: 22406116
[TBL] [Abstract][Full Text] [Related]
30. Roles of the receptor tyrosine kinases Tie1 and Tie2 in mediating the effects of angiopoietin-1 on endothelial permeability and apoptosis.
Milner CS; Hansen TM; Singh H; Brindle NP
Microvasc Res; 2009 Mar; 77(2):187-91. PubMed ID: 18848573
[TBL] [Abstract][Full Text] [Related]
31. [Expression of Ang2 and Tie2 and their relation with the angiogenesis of hepatocellular carcinoma in rats].
Li WZ; Yang P; Peng GC; Tang HH; Zhou J; Fu CY; Feng DY; Zhou X; Huang MP; Zhou GF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):523-7. PubMed ID: 16951510
[TBL] [Abstract][Full Text] [Related]
32. Structures of dimeric nonstandard nucleotide triphosphate pyrophosphatase from Pyrococcus horikoshii OT3: functional significance of interprotomer conformational changes.
Lokanath NK; Pampa KJ; Takio K; Kunishima N
J Mol Biol; 2008 Jan; 375(4):1013-25. PubMed ID: 18062990
[TBL] [Abstract][Full Text] [Related]
33. Structures of the extracellular regions of the group II/III metabotropic glutamate receptors.
Muto T; Tsuchiya D; Morikawa K; Jingami H
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3759-64. PubMed ID: 17360426
[TBL] [Abstract][Full Text] [Related]
34. Angiopoietins and angiopoietin-like proteins in angiogenesis.
Morisada T; Kubota Y; Urano T; Suda T; Oike Y
Endothelium; 2006; 13(2):71-9. PubMed ID: 16728326
[TBL] [Abstract][Full Text] [Related]
35. Angiopoietin-mediated endothelial P-selectin translocation: cell signaling mechanisms.
Maliba R; Brkovic A; Neagoe PE; Villeneuve LR; Sirois MG
J Leukoc Biol; 2008 Feb; 83(2):352-60. PubMed ID: 17984290
[TBL] [Abstract][Full Text] [Related]
36. Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor.
Yuzawa S; Opatowsky Y; Zhang Z; Mandiyan V; Lax I; Schlessinger J
Cell; 2007 Jul; 130(2):323-34. PubMed ID: 17662946
[TBL] [Abstract][Full Text] [Related]
37. Crystal structure analysis and solution studies of human Lck-SH3; zinc-induced homodimerization competes with the binding of proline-rich motifs.
Romir J; Lilie H; Egerer-Sieber C; Bauer F; Sticht H; Muller YA
J Mol Biol; 2007 Feb; 365(5):1417-28. PubMed ID: 17118402
[TBL] [Abstract][Full Text] [Related]
38. Acute resistance exercise increases skeletal muscle angiogenic growth factor expression.
Gavin TP; Drew JL; Kubik CJ; Pofahl WE; Hickner RC
Acta Physiol (Oxf); 2007 Oct; 191(2):139-46. PubMed ID: 17565567
[TBL] [Abstract][Full Text] [Related]
39. The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1.
Simon MP; Tournaire R; Pouyssegur J
J Cell Physiol; 2008 Dec; 217(3):809-18. PubMed ID: 18720385
[TBL] [Abstract][Full Text] [Related]
40. Development of an Orthogonal Tie2 Ligand Resistant to Inhibition by Ang2.
Issa E; Moss AJ; Fischer M; Kang M; Ahmed S; Farah H; Bate N; Giakomidi D; Brindle NP
Mol Pharm; 2018 Sep; 15(9):3962-3968. PubMed ID: 30036484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
